NCT04072432View on ClinicalTrials.gov

A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 21, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

August 26, 2019

Conditions
Healthy VolunteersChronic Kidney Disease
Interventions
DRUG

RBT-3

intravenous administration

Trial Locations (1)

32132

Riverside Clinical Research, Edgewater

All Listed Sponsors
lead

Renibus Therapeutics, Inc.

INDUSTRY

NCT04072432 - A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease | Biotech Hunter | Biotech Hunter